Avid Bioservices, Inc.

NASDAQ:CDMO

11.6 (USD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995
Revenue 139.911149.266119.59795.86859.70253.60353.62157.6344.68626.78122.40121.68315.23313.49227.94318.1516.0933.7083.1934.9593.3143.9213.7660.9790.0010.10.50.33.10.1
Cost of Revenue 132.593117.78682.94966.56155.7746.37956.54538.25922.96615.59313.1112.59510.1537.2968.7169.0644.8043.2963.2974.4012.2122.860-0.412-0.5163.5-0.7-0.301
Gross Profit 7.31831.4836.64829.3073.9327.224-2.92419.37121.7211.1889.2919.0885.086.19619.2279.0871.2890.412-0.1040.5581.1021.0613.7661.3910.517-3.41.20.63.1-0.9
Gross Profit Ratio 0.0520.2110.3060.3060.0660.135-0.0550.3360.4860.4180.4150.4190.3330.4590.6880.5010.2120.111-0.0330.1130.3330.27111.421517-342.421-9
Reseach & Development Expenses 000000028.29759.52942.99627.72324.30635.68829.46224.65818.42418.27915.87612.41511.1649.6738.74413.5067.388.0758.87.6301.70
General & Administrative Expenses 25.19627.17920.62616.76414.317000000000000000002.4783.8124.2366.24.53.30.90.7
Selling & Marketing Expenses 0.80.70.60.30.20000000000000000000000000
SG&A 25.99627.87921.22617.06414.51712.84616.45619.33418.55118.69117.27413.13411.46211.4218.1826.9797.156.4466.5645.0984.2252.9872.4783.8124.2366.24.53.30.90.7
Other Expenses -3.9121.002-0.0810.1330.35501.25800000000000000000.4120.51610.70.30.20.2
Operating Expenses 25.99627.87921.22617.06414.51712.84616.45647.63178.0861.68744.99737.4447.1540.88332.8425.40325.42922.32218.97916.26213.89811.73115.98411.60412.8271612.833.62.80.9
Operating Income -18.678-2.60710.8618.923-10.585-5.622-20.638-28.26-56.36-50.499-35.706-28.352-42.07-34.687-13.613-16.316-24.14-21.91-19.083-15.704-12.796-10.67-12.218-10.213-12.31-19.4-11.6-330.3-1.8
Operating Income Ratio -0.133-0.0170.0910.093-0.177-0.105-0.385-0.49-1.261-1.886-1.594-1.308-2.762-2.571-0.487-0.899-3.962-5.909-5.977-3.167-3.861-2.721-3.244-10.432-12,310-194-23.2-1100.097-18
Total Other Income Expenses Net -8.2494.611.82.2890.1190.282-1.2580.1010.7080.1410.344-1.696536,000536,000-881,000-208,000001.2290-1.54900-0.009-2.190.400-0.2-5
Income Before Tax -26.9272.00312.66111.212-10.466-5.34-20.563-28.159-55.652-50.358-35.362-29.78-34,151,000-34,151,000-14,494,000-16,524,00000-17.8540-14.34500-10.222-14.5-19000.1-6.8
Income Before Tax Ratio -0.1920.0130.1060.117-0.175-0.1-0.383-0.489-1.245-1.88-1.579-1.373-2,241,909.013-2,531,203.676-518,698.78-910,363.06500-5.5920-4.32900-10.441-14,500-190000.032-68
Income Tax Expense 113.8261.443-115.011-2.289-3.21-0.284-1.285-2.3550.7220.1420.349-1.033535,999.141535,998.812-880,999.119-207,999.792-0.964-1.114-2.022-0.25200.889-0.5-0.6782.2040.10.20.205.1
Net Income -140.7530.56127.67211.212-7.256-4.215-21.813-28.159-55.652-50.358-35.362-29.78-42.119-34.151-14.494-16.524-23.176-20.796-17.061-15.452-14.345-11.559-11.718-9.535-14.514-19.5-11.8-33.20.3-6.9
Net Income Ratio -1.0060.0041.0680.117-0.122-0.079-0.407-0.489-1.245-1.88-1.579-1.373-2.765-2.531-0.519-0.91-3.804-5.608-5.343-3.116-4.329-2.948-3.112-9.74-14,514-195-23.6-110.6670.097-69
EPS -2.230.0092.080.057-0.13-0.075-0.46-0.76-1.8-1.93-1.53-1.73-3.53-3.93-2.07-2.56-3.67-3.79-3.55-3.73-3.74-3.47-3.92-3.51-6.26-10.32-13.35-54.250.7-15.4
EPS Diluted -2.230.0091.810.056-0.13-0.075-0.46-0.76-1.8-1.93-1.53-1.73-3.53-3.93-2.07-2.56-3.67-3.79-3.55-3.73-3.74-3.47-3.92-3.51-6.26-10.32-13.35-54.250.7-15.4
EBITDA -7.5694.60315.34112.376-10.23-5.622-19.278-28.152-54.103-49.316-34.371-28.03-42.07-34.687-12.497-15.813-23.654-21.044-19.897-15.379-10.611-9.289-11.794-9.792-9.604-18.8-10.9-32.70.73.4
EBITDA Ratio -0.0540.0310.1280.129-0.171-0.105-0.36-0.488-1.211-1.841-1.534-1.293-2.762-2.571-0.447-0.871-3.882-5.675-6.231-3.101-3.202-2.369-3.132-10.002-9,604-188-21.8-1090.22634